Ampio prepares FDA protocol to study Ampion as treatment for COVID-19 Acute Respiratory Distress

Ampio prepares FDA protocol to study Ampion as treatment for COVID-19 Acute Respiratory Distress

ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE American: AMPE) announced it is preparing an expanded access FDA protocolto study potential benefit of nebulized treatment with Ampion in SARS-Cov-2... Read More

Wednesday March 25, 2020 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, COVID-19

19 Startling COVID trends and 19 golden COVID opportunities emerging from the chaos

19 Startling COVID trends and 19 golden COVID opportunities emerging from the chaos

By Thomas Frey Senior Futurist The Davinci Institute As Chicago Mayor Rahm Emanuel once said, You should never let a serious crisis go to waste! Were entering unprecedented... Read More

By: Thomas Frey Monday March 23, 2020 0 comments Tags: Thomas Frey, COVID-19, coronavirus

Greffex completes COVID-19 vaccine, prepares for FDA animal testing

Greffex completes COVID-19 vaccine, prepares for FDA animal testing

HOUSTON/AURORA -- Texas-based genetic engineering company Greffex, Inc. announced it has completed development of a Covid-19 vaccine and is ready to move on to animal testing as required by the U.S.... Read More

Thursday March 12, 2020 0 comments Tags: Aurora, Greffex, John Price, COVID-19, coronavirus